Every Hayes publication is developed by multidisciplinary teams of clinicians and scientists using rigorous methods grounded in internally recognized standards for systematic review and Health Technology Assessment. Learn more about these evidence resources and see sample titles below.
See below for some of our recent publications.
Focus of the Report: The focus of this Health Technology Assessment (HTA) is the evaluation of the effectiveness and safety of proton beam therapy (PBT) compared with conventional (photon-based) external beam radiation therapies for the treatment of esophageal adenocarcinoma (EAC) in adults.
…
This report reviews clinical study abstracts and clinical practice guidelines addressing comprehensive molecular profiling (CMP) of circulating solid tumor DNA as a broad molecular profiling tool to aid in monitoring for indicators of treatment response/failure or tumor progression. This report will focus solely on free ctDNA detected in plasma separated from whole blood samp…
This report reviews clinical study abstracts and clinical practice guidelines addressing comprehensive molecular profiling (CMP) of circulating solid tumor DNA as a broad molecular profiling tool to aid in decision making regarding biomarker-matched treatment selection (including U.S. Food and Drug Administration [FDA]-approved or off-label use). This report will focus solely…
Revita DMR is an investigational endoscopic hydrothermal ablation device for duodenal mucosal resurfacing proposed for treatment of type 2 diabetes that is poorly controlled with oral medications and/or insulin.
Focus of the Report: The focus of this Health Technology Assessment (HTA) is to evaluate the safety and effectiveness of proton beam therapy (PBT) for the treatment of breast cancer with no distant metastasis. This HTA also compares the safety and effectiveness of PBT with conventional radiation therapies.
CureSight is a software-based prescription digital therapeutic for treatment of amblyopia that utilizes eye tracking technology to improve visual acuity and stereo acuity by training the visual system to use both eyes simultaneously.
AuroLase is a focal ablation therapy that uses gold nanoparticles and a near-infrared laser to thermally ablate localized prostate cancer.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of accelerated repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression.
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of Zio monitors for heart rhythm monitoring in pediatric patients.
Skysona (elivaldogene autotemcel; eli-cel) is lentiviral-based gene therapy indicated to slow the progression of neurologic dysfunction in boys 4-17 years of age with early, active cerebral adrenoleukodystrophy (CALD).